Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

341 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnosis and treatment of systemic mastocytosis in Brazil: Recommendations of a multidisciplinary expert panel.
Velloso EDRP, Padulla GA, de Cerqueira AMM, de Sousa AM, Sandes AF, Traina F, Seguro FS, Nogueira FL, Pereira GF, Boechat JL, Pagnano KBB, Marchi LL, Ensina LF, Giavina-Bianchi M, Aun MV, Agondi RC, Santos FPS, Giavina-Bianchi P. Velloso EDRP, et al. Among authors: traina f. Hematol Transfus Cell Ther. 2022 Oct-Dec;44(4):582-594. doi: 10.1016/j.htct.2022.04.006. Epub 2022 May 26. Hematol Transfus Cell Ther. 2022. PMID: 35688791 Free PMC article.
Conventional chemotherapy for acute myeloid leukemia: a Brazilian experience.
Pagnano KB, Traina F, Takahashi T, Oliveira GB, Rossini MS, Lorand-Metze I, Vigorito AC, Miranda EC, De Souza CA. Pagnano KB, et al. Among authors: traina f. Sao Paulo Med J. 2000 Nov 9;118(6):173-8. doi: 10.1590/s1516-31802000000600005. Sao Paulo Med J. 2000. PMID: 11120548 Free article. Clinical Trial.
Identification of target genes using gene expression profile of granulocytes from patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.
Mascarenhas Cdo C, Ferreira da Cunha A, Brugnerotto AF, Gambero S, de Almeida MH, Carazzolle MF, Pagnano KB, Traina F, Costa FF, de Souza CA. Mascarenhas Cdo C, et al. Among authors: traina f. Leuk Lymphoma. 2014 Aug;55(8):1861-9. doi: 10.3109/10428194.2013.855311. Epub 2014 Feb 4. Leuk Lymphoma. 2014. PMID: 24144310
Clinical features of JAK2V617F- or CALR-mutated essential thrombocythemia and primary myelofibrosis.
Monte-Mor Bda C, Ayres-Silva Jde P, Correia WD, Coelho AC, Solza C, Daumas AH, Bonamino MH, Santos FP, Datoguia TS, Pereira Wde O, Lisboa BC, Ramos CF, Machado-Neto JA, Hamerschlak N, Campregher PV, Traina F, Pagnano KB, Zalcberg I. Monte-Mor Bda C, et al. Among authors: traina f. Blood Cells Mol Dis. 2016 Sep;60:74-7. doi: 10.1016/j.bcmd.2016.03.003. Epub 2016 Mar 8. Blood Cells Mol Dis. 2016. PMID: 26994960 Clinical Trial. No abstract available.
Erratum on "Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation".
Cacemiro MDC, Cominal JG, Tognon R, Nunes NS, Simões BP, Lôbo de Figueiredo-Pontes L, Bazzo Catto LF, Traina F, Xisto Souto E, Albani Zambuzi F, Frantz FG, de Castro FA. Cacemiro MDC, et al. Among authors: traina f. Hematol Transfus Cell Ther. 2021 Jan-Mar;43(1):117. doi: 10.1016/j.htct.2020.11.001. Epub 2020 Nov 25. Hematol Transfus Cell Ther. 2021. PMID: 33531280 Free PMC article. No abstract available.
Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation.
Cacemiro MDC, Cominal JG, Tognon R, Nunes NS, Simões BP, Figueiredo-Pontes LL, Catto LFB, Traina F, Souto EX, Zambuzi FA, Frantz FG, Castro FA. Cacemiro MDC, et al. Among authors: traina f. Hematol Transfus Cell Ther. 2018 Apr-Jun;40(2):120-131. doi: 10.1016/j.htct.2017.12.003. Epub 2018 Feb 17. Hematol Transfus Cell Ther. 2018. PMID: 30057985 Free PMC article.
ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia.
Lipreri da Silva JC, Coelho-Silva JL, Vicari HP, Lima K, Rego EM, Traina F, Machado-Neto JA. Lipreri da Silva JC, et al. Among authors: traina f. Hematol Transfus Cell Ther. 2024 Jan-Mar;46(1):101-105. doi: 10.1016/j.htct.2023.06.004. Epub 2023 Jul 31. Hematol Transfus Cell Ther. 2024. PMID: 37541806 Free PMC article. No abstract available.
Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412.
de Melo Campos P, Machado-Neto JA, Scopim-Ribeiro R, Visconte V, Tabarroki A, Duarte AS, Barra FF, Vassalo J, Rogers HJ, Lorand-Metze I, Tiu RV, Costa FF, Olalla Saad ST, Traina F. de Melo Campos P, et al. Among authors: traina f. Leuk Res. 2014 Oct;38(10):1245-51. doi: 10.1016/j.leukres.2014.07.010. Epub 2014 Aug 1. Leuk Res. 2014. PMID: 25139846 Free article.
341 results